Expertise in
4
conditions

David Cuadron-Martinez

Avda. Fernando Abril Martorell 106, CP, 
Valencia, VC, ES 
Expertise in
4
conditions
Avda. Fernando Abril Martorell 106, CP, 
Valencia, VC, ES 

Overview

David Cuadron-Martinez practices practicing medicine in Valencia, Spain.

Mr. Cuadron-Martinez is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Leukocytosis, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 112 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Avda. Fernando Abril Martorell 106, CP, Valencia, VC 46026, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 2:1 Randomized Phase II Trial to Compare the Efficacy and Safety of Standard Chemotherapy Plus Quizartinib Versus Standard Chemotherapy Plus Placebo in Adult Patients With Newly Diagnosed FLT3 Wild-type AML
A 2:1 Randomized Phase II Trial to Compare the Efficacy and Safety of Standard Chemotherapy Plus Quizartinib Versus Standard Chemotherapy Plus Placebo in Adult Patients With Newly Diagnosed FLT3 Wild-type AML
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drugs: Quizartinib, Cytarabine, Idarubicin
Study Phase: Phase 2

112 Total Publications

Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.
Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.
Journal: American journal of hematology
Published: April 24, 2026

Frequently Asked Questions about David Cuadron-Martinez

Is David Cuadron-Martinez a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. David Cuadron-Martinez is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David Cuadron-Martinez participate in research or clinical trials?

Yes. David Cuadron-Martinez has published 112 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of David Cuadron-Martinez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cuadron-Martinez's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile